Cumberland Pharmaceuticals (CPIX) Return on Capital Employed: 2009-2024
Historic Return on Capital Employed for Cumberland Pharmaceuticals (CPIX) over the last 16 years, with Dec 2024 value amounting to -0.14%.
- Cumberland Pharmaceuticals' Return on Capital Employed rose 15.00% to -0.08% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.08%, marking a year-over-year increase of 15.00%. This contributed to the annual value of -0.14% for FY2024, which is 2.00% up from last year.
- Per Cumberland Pharmaceuticals' latest filing, its Return on Capital Employed stood at -0.14% for FY2024, which was up 15.07% from -0.16% recorded in FY2023.
- Over the past 5 years, Cumberland Pharmaceuticals' Return on Capital Employed peaked at -0.09% during FY2020, and registered a low of -0.16% during FY2023.
- Its 3-year average for Return on Capital Employed is -0.13%, with a median of -0.14% in 2024.
- Its Return on Capital Employed has fluctuated over the past 5 years, first climbed by 2bps in 2020, then declined by 7bps in 2023.
- Yearly analysis of 5 years shows Cumberland Pharmaceuticals' Return on Capital Employed stood at -0.09% in 2020, then dropped by 2bps to -0.11% in 2021, then increased by 1bps to -0.09% in 2022, then dropped by 7bps to -0.16% in 2023, then rose by 2bps to -0.14% in 2024.